Avalo Therapeutics Inc.

NASDAQ: AVTX · Real-Time Price · USD
4.71
-0.05 (-1.05%)
At close: Jun 27, 2025, 3:59 PM
4.78
1.49%
After-hours: Jun 27, 2025, 04:04 PM EDT

Avalo Therapeutics Revenue

Avalo Therapeutics reported an annual revenue of $441K, reflecting a -77.08% growth. For the quarter ending March 31, 2025, Avalo Therapeutics generated $0 in revenue.
Revenue (ttm)
$441K
Revenue Growth
-77.08%
Price / Sales Ratio
136.95
Revenue / Employee
$19.17K
Employees
23
Market Cap
51M

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.